{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:47:20Z","timestamp":1793933240176,"version":"4.8.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UIDB\/00100\/2020"],"award-info":[{"award-number":["UIDB\/00100\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jinorgbio.2024.112813","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T22:28:54Z","timestamp":1734215334000},"page":"112813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A critical analysis of the potential of iron heterobimetallic complexes in anticancer research"],"prefix":"10.1016","volume":"264","author":[{"given":"Bogl\u00e1rka","family":"T\u0171z","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo N.","family":"Martinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2024.112813_bb0005","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJM199705293362206","article-title":"Cancer undefeated","volume":"336","author":"Bailar","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/biomedicines9050504","article-title":"Strategies for the improvement of metal-based chemotherapeutic treatments","volume":"9","author":"Cirri","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/molecules28010273","article-title":"Highlights of new strategies to increase the efficacy of transition metal complexes for cancer treatments","volume":"28","author":"Giorgi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0020","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.428","article-title":"Systems biology of cisplatin resistance: past, present and future","volume":"5","author":"Galluzzi","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0030","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1039\/C3SC53243G","article-title":"NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application","volume":"5","author":"Trondl","year":"2014","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0035","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1039\/c3cc41143e","article-title":"Exploration of the medical periodic table: towards new targets","volume":"49","author":"Barry","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0040","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/cmdc.202000833","article-title":"Theranostics through the synergistic cooperation of heterometallic complexes","volume":"16","author":"Redrado","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.poly.2019.02.009","article-title":"Investigation of crystallographic structure, in vitro cytotoxicity and DNA interaction of two La(III) and Ce(IV) complexes containing dipicolinic acid and 4-dimethylaminopyridine","volume":"163","author":"Adibi","year":"2019","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/00958972.2022.2039916","article-title":"Study on a Ru(III) complex containing picolinate with potent inhibition effect against melanoma cell line","volume":"75","author":"Abdolmaleki","year":"2022","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131327","article-title":"Green synthesis, X-ray crystal structure, evaluation as in vitro cytotoxic and antibacterial agents of a new Zn(II) complex containing dipicolinic acid","volume":"1247","author":"Aliabadi","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/metabo6040033","article-title":"The redox status of cancer cells supports mechanisms behind the Warburg effect","volume":"6","author":"Moreira","year":"2016","journal-title":"Metabolites"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215579","article-title":"Riding the metal wave: a review of the latest developments in metal-based anticancer agents","volume":"501","author":"Abdolmaleki","year":"2024","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0070","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/ejic.201900375","article-title":"Heterometallic multinuclear complexes as anti-cancer agents-an overview of recent developments","volume":"2019","author":"van Niekerk","year":"2019","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0075","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3390\/ijms18071415","article-title":"Theranostic liposome\u2013nanoparticle hybrids for drug delivery and bioimaging","volume":"18","author":"Seleci","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/02603594.2014.890099","article-title":"Targeted chemotherapy with metal complexes","volume":"34","author":"Weidmann","year":"2014","journal-title":"Comments Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1103\/RevModPhys.28.53","article-title":"Abundances of the elements","volume":"28","author":"Suess","year":"1956","journal-title":"Rev. Mod. Phys."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2020.213339","article-title":"Recent advances in the chemistry of iron-based chemotherapeutic agents","volume":"417","author":"Basu","year":"2020","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0095","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1021\/om300373t","article-title":"Challenges and opportunities in the development of organometallic anticancer drugs","volume":"31","author":"Hartinger","year":"2012","journal-title":"Organometallics"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0100","first-page":"1","article-title":"Metal complexes in target-specific anticancer therapy: recent trends and challenges","volume":"2022","author":"Shumi","year":"2022","journal-title":"J. Chemother."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0105","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1021\/bc200151q","article-title":"Theranostics: combining imaging and therapy","volume":"22","author":"Kelkar","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.poly.2022.116178","article-title":"Polypyridyl coordinated rhenium(I) tricarbonyl complexes as model devices for cancer diagnosis and treatment","volume":"228","author":"Moherane","year":"2022","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0115","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20212160","article-title":"Challenges and opportunities in the development of metal-based anticancer theranostic agents","volume":"42","author":"Vaidya","year":"2022","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0120","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/ar800255q","article-title":"Molecular imaging of Cancer with Copper-64 radiopharmaceuticals and positron emission tomography (PET)","volume":"42","author":"Shokeen","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300521","article-title":"Key insights on the classification and Theranostic applications of magnetic resonance imaging contrast agents","author":"Kaur","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0130","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1039\/C5CC09718E","article-title":"Versatile synthesis of cationic N-heterocyclic carbene\u2013gold(I) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium\u2013gold anticancer agents","volume":"52","author":"Fern\u00e1ndez-Gallardo","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0135","doi-asserted-by":"crossref","first-page":"9885","DOI":"10.1002\/chem.202100707","article-title":"Multifunctional heterometallic Ir(III) \u2212Au(I) probes as promising anticancer and antiangiogenic agents","volume":"27","author":"Redrado","year":"2021","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2019.120918","article-title":"Anticancer study of heterobimetallic platinum(II)-ruthenium(II) and platinum(II)-rhodium(III) complexes with bridging dithiooxamide ligand","volume":"900","author":"Askari","year":"2019","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0145","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/ejic.201801297","article-title":"Heterobimetallic Pt(II) -Au(I) complexes comprising unsymmetrical 1,1-Bis(diphenylphosphanyl)methane bridges: synthesis, photophysical, and cytotoxic studies","volume":"2019","author":"Shahsavari","year":"2019","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ccr.2018.06.014","article-title":"Rational design of phosphorescent iridium(III) complexes for emission color tunability and their applications in OLEDs","volume":"374","author":"Li","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0155","article-title":"Spectral tuning and emission enhancement through lanthanide coordination in a dual Vis-NIR emissive cyanide-bridged heterometallic Ru(II)-Er(III) complex","author":"Mara","year":"2024","journal-title":"ChemRxiv"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0160","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1039\/D2QI00205A","article-title":"Platinum-containing heterometallic complexes in cancer therapy: advances and perspectives","volume":"9","author":"Ma","year":"2022","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112613","article-title":"A review on 1,1-bis(diphenylphosphino)methane bridged homo- and heterobimetallic complexes for anticancer applications: synthesis, structure, and cytotoxicity","volume":"204","author":"Odachowski","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0170","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/jm100020w","article-title":"Organometallic anticancer compounds","volume":"54","author":"Gasser","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0180","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1039\/C5CS00486A","article-title":"Ferrocifen type anti cancer drugs","volume":"44","author":"Jaouen","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0185","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1021\/om400446y","article-title":"A new age for iron: antitumoral ferrocenes","volume":"32","author":"Braga","year":"2013","journal-title":"Organometallics"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/s41570-017-0066","article-title":"The medicinal chemistry of ferrocene and its derivatives","volume":"1","author":"Patra","year":"2017","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0195","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s11626-015-9919-6","article-title":"Some ferrocenyl chalcones as useful candidates for cancer treatment","volume":"51","author":"Janka","year":"2015","journal-title":"In Vitro Cell. Dev. Biol. Animal"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0200","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1039\/C1DT11358E","article-title":"Heterometallic platinum(II) compounds with \u03b2-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity","volume":"41","author":"Nieto","year":"2012","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0205","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/aoc.1626","article-title":"Synthesis and anticancer activity of chalcogenide derivatives and platinum(II) and palladium(II) complexes derived from a polar ferrocene phosphanyl\u2013carboxamide","volume":"24","author":"Schulz","year":"2010","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0210","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jorganchem.2004.01.034","article-title":"Synthesis, characterization and cytotoxicity of some palladium(II), platinum(II), rhodium(I) and iridium(I) complexes of ferrocenylpyridine and related ligands. Crystal and molecular structure of trans-dichlorobis(3-ferrocenylpyridine)palladium(II)","volume":"689","author":"Rajput","year":"2004","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0215","first-page":"1","article-title":"Heterometallic ferrocenyl complexes and their application in the treatment of cancer","author":"Lord","year":"2022","journal-title":"Encyclop. Inorg. Bioinorg. Chem. (Wiley)"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0220","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1021\/acs.organomet.5b00751","article-title":"Catalytically generated ferrocene-containing guanidines as efficient precursors for new redox-active heterometallic platinum(II) complexes with anticancer activity","volume":"34","author":"Nieto","year":"2015","journal-title":"Organometallics"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2019.110779","article-title":"Pt-Fe ferrocenyl compounds with hydroxyquinoline ligands show selective cytotoxicity on highly proliferative cells","volume":"199","author":"Rivas","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0230","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ica.2014.03.018","article-title":"Palladium(II) carbohydrate complexes of alkyl, aryl and ferrocenyl esters and their cytotoxic activitie","volume":"416","author":"Deepthi","year":"2014","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0235","article-title":"Synthesis and anticancer properties of heterobimetallic Fe(II)\/Pd(II) complexes bearing different butadienyl fragments","author":"Scattolin","year":"2024","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0240","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1039\/C8CC03308K","article-title":"Assessment of the antitumor activity of a cyclopalladated ferrocene compound assisted by a dual-targeting drug delivery system","volume":"54","author":"Gong","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0245","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1039\/C7DT02887C","article-title":"The cytotoxicity and mechanism of action of new multinuclear Scaffold Au(III), Pd(II) pincer complexes containing a bis(diphenylphosphino) ferrocene\/non-ferrocene ligand","volume":"46","author":"Tabrizi","year":"2017","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0250","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1039\/C5SC03519H","article-title":"Targeting antioxidant pathways with ferrocenylated N-heterocyclic carbene supported gold(I) complexes in A549 lung cancer cells","volume":"7","author":"Arambula","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0255","doi-asserted-by":"crossref","first-page":"18953","DOI":"10.1002\/chem.201604246","article-title":"Ferrocenyl-coupled N-heterocyclic Carbene complexes of gold(I): a successful approach to multinuclear anticancer drugs","volume":"22","author":"Muenzner","year":"2016","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0260","doi-asserted-by":"crossref","first-page":"16072","DOI":"10.1039\/C8DT03116A","article-title":"Synthesis of heterobimetallic gold(I) ferrocenyl-substituted 1,2,3-triazol-5-ylidene complexes as potential anticancer agents","volume":"47","author":"Aucamp","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0265","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1039\/D1DT01326B","article-title":"Ru(II), Ir(III), Re(I) and Rh(III) based complexes as next generation anticancer metallopharmaceuticals","volume":"50","author":"Das","year":"2021","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0270","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.abb.2017.10.015","article-title":"Ru\/Fe bimetallic complexes: synthesis, characterization, cytotoxicity and study of their interactions with DNA\/HSA and human topoisomerase IB","volume":"636","author":"Takarada","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0275","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1039\/c9mt00272c","article-title":"Heterobimetallic Ru(II)\/Fe(II) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets","volume":"12","author":"Guedes","year":"2020","journal-title":"Metallomics"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0280","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.abb.2018.10.020","article-title":"Carbonyl\u2013heterobimetallic Ru(II)\/Fe(II)\u2013complexes containing polypyridyl ligands: synthesis, characterization, cellular viability assays and interactions with biomolecules","volume":"660","author":"Rodriguez","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0285","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/acs.inorgchem.5b02109","article-title":"Induction of cytotoxicity in pyridine analogues of the anti-metastatic Ru(III) complex NAMI-A by ferrocene functionalization","volume":"55","author":"Mu","year":"2016","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0290","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1021\/acs.organomet.8b00604","article-title":"Newly synthesized heteronuclear ruthenium(II)\/ferrocene complexes suppress the growth of mammary carcinoma in 4T1-treated BALB\/c mice by promoting activation of antitumor immunity","volume":"37","author":"Milutinovi\u0107","year":"2018","journal-title":"Organometallics"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0295","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejmech.2014.06.052","article-title":"Interaction of ferrocene appended Ru(II), Rh(III) and Ir(III) dipyrrinato complexes with DNA\/protein, molecular docking and antitumor activity","volume":"84","author":"Paitandi","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0300","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00775-018-1567-3","article-title":"Impact of various lipophilic substituents on ruthenium(II), rhodium(III) and iridium(III) salicylaldimine-based complexes: synthesis, in vitro cytotoxicity studies and DNA interactions","volume":"23","author":"Cassells","year":"2018","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jorganchem.2015.04.009","article-title":"Synthesis, characterization and pharmacological evaluation of ferrocenyl azines and their rhodium(I) complexes","volume":"788","author":"Stringer","year":"2015","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0310","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jorganchem.2018.10.017","article-title":"New bioactive ferrocene-substituted heteroleptic copper(I) complex: synthesis, structural elucidation, DNA interaction, and DFT study","volume":"879","author":"Zubair","year":"2019","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0315","doi-asserted-by":"crossref","first-page":"12308","DOI":"10.1039\/C9NJ02068C","article-title":"First heterobimetallic cu(I)\u2013dppf complexes designed for anticancer applications: synthesis, structural characterization and cytotoxicity","volume":"43","author":"Bravo","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2023.122972","article-title":"Heterobimetallic Fe(II)\u2013cu(I) complexes supported with 1,1\u2032-Bis(diphenylphosphino)ferrocene and chelating sulfur donor ligands: structural characterization, DFT analysis, anti-tyrosinase assay and biological studies","volume":"1005","author":"Neshat","year":"2024","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0325","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1039\/D3DT01070H","article-title":"Synthesis, characterisation and biological evaluation of monometallic Re(I) and heterobimetallic Re(I)\/Fe(II) complexes with a 1,2,3-triazolyl pyridine chelating moiety","volume":"52","author":"Jakopec","year":"2023","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0330","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1021\/acs.organomet.8b00278","article-title":"Syntheses, structural snapshots, solution redox properties, and cytotoxic performances of designated ferrocene scaffolds appended with Organostannyl(IV) benzoates en route for human hepatic carcinoma","volume":"37","author":"Basu Baul","year":"2018","journal-title":"Organometallics"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0335","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejmech.2014.05.023","article-title":"Ferrocenyl and dicobalt hexacarbonyl chromones \u2013 new organometallics inducing oxidative stress and arresting human cancer cells in G2\/M phase","volume":"81","author":"Kowalski","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2019.120934","article-title":"Heterobimetallic Ru(\u03bc-dppm)Fe and homobimetallic Ru(\u03bc-dppm)Ru complexes as potential anti-cancer agents","volume":"901","author":"Herry","year":"2019","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2020.119731","article-title":"Facile synthesis of heterobimetallic [FeII(\u03bc-diphosphine)RuII] and homobimetallic [FeII(\u03bc-diphosphine)FeII] complexes and their in vitro cytotoxic activity on cisplatin-resistant cancer cells","volume":"510","author":"BenYosef","year":"2020","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112156","article-title":"Ionic mononuclear [Fe] and heterodinuclear [Fe,Ru] bis(diphenylphosphino)alkane complexes: Synthesis, spectroscopy, DFT structures, cytotoxicity, and biomolecular interactions","volume":"242","author":"Odachowski","year":"2023","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2020.121659","article-title":"Ionic ruthenium and iron based complexes bearing silver containing anions as a potent new class of anticancer agents","volume":"934","author":"Benamrane","year":"2021","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0360","doi-asserted-by":"crossref","DOI":"10.1039\/D4CC03092C","article-title":"Manipulating Fe(II) spin states to achieve higher anti-tumor cell activities in multinuclear complexes","author":"Yao","year":"2024","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0365","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.7150\/thno.54227","article-title":"Recent advances in innovative strategies for enhanced cancer photodynamic therapy","volume":"11","author":"Hu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0370","doi-asserted-by":"crossref","DOI":"10.1098\/rsta.2012.0519","article-title":"Photoactivatable metal complexes: from theory to applications in biotechnology and medicine","volume":"371","author":"Smith","year":"2013","journal-title":"Philos. Trans. R. Soc. A"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0375","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/187152007779314053","article-title":"Photoactivatable platinum complexes","volume":"7","author":"Bednarski","year":"2007","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102303","article-title":"Beyond mere DNA damage: recent progress in platinum(IV) anticancer complexes containing multi-functional axial ligands","volume":"74","author":"Deng","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0385","doi-asserted-by":"crossref","first-page":"20745","DOI":"10.1021\/acs.inorgchem.3c02245","article-title":"Radiometal-labeled photoactivatable Pt(IV) anticancer complex for Theranostic phototherapy","volume":"62","author":"Imberti","year":"2023","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0390","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1039\/C3DT51922H","article-title":"Remarkable anticancer activity of ferrocenyl-terpyridine platinum(II) complexes in visible light with low dark toxicity","volume":"43","author":"Mitra","year":"2014","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0395","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1021\/acs.inorgchem.6b00680","article-title":"Biotinylated platinum(II) Ferrocenylterpyridine complexes for targeted Photoinduced cytotoxicity","volume":"55","author":"Mitra","year":"2016","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0400","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00775-021-01899-z","article-title":"Co(II) complexes of curcumin and a ferrocene-based curcuminoid: a study on photo-induced antitumor activity","volume":"26","author":"Das","year":"2021","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12325-015-0275-4","article-title":"25 years of contrast-enhanced MRI: developments, current challenges and future perspectives","volume":"33","author":"Lohrke","year":"2016","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0410","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbab062","article-title":"Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics","volume":"8","author":"Wu","year":"2021","journal-title":"Regener. Biomater."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wnan.1198","article-title":"Gadolinium-based contrast agents for magnetic resonance cancer imaging","volume":"5","author":"Zhou","year":"2013","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0420","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1522-2586(200008)12:2<358::AID-JMRI20>3.0.CO;2-T","article-title":"Synergistic effect between iron and gadolinium in MRI","volume":"12","author":"Luboldt","year":"2000","journal-title":"J. Magn. Reason. Imag."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0425","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.inoche.2011.09.006","article-title":"A self-assembly heterotrinuclear gadolinium(III)\u2013iron(II) complex as a MRI contrast agent","volume":"14","author":"Li","year":"2011","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0430","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/anie.200461875","article-title":"High Relaxivity confined to a small molecular space: a Metallostar-based, potential MRI contrast agent","volume":"44","author":"Livramento","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0435","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1522-2586(199902)9:2<348::AID-JMRI30>3.0.CO;2-J","article-title":"Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates","volume":"9","author":"Bryant","year":"1999","journal-title":"J. Magn. Reason. Imag."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0440","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/cmmi.114","article-title":"Pharmacokinetic andin vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity","volume":"1","author":"Parac-Vogt","year":"2006","journal-title":"Contrast Media Mol. Imag."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0445","doi-asserted-by":"crossref","first-page":"50445","DOI":"10.1021\/acsami.2c10272","article-title":"Recent advances in metal\u2013organic frameworks for applications in magnetic resonance imaging","volume":"14","author":"Bunzen","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0450","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ejic.201801412","article-title":"Rational design of tetranuclear complexes employing N -imidoylamidine based ligands","volume":"2019","author":"Casta\u00f1eda","year":"2019","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0455","article-title":"Cluster-based redox-responsive super-atomic MRI contrast agents","author":"Kitos","year":"2024","journal-title":"Chem"},{"issue":"3","key":"10.1016\/j.jinorgbio.2024.112813_bb0460","doi-asserted-by":"crossref","first-page":"202","DOI":"10.26650\/IstanbulJPharm.2020.0039","article-title":"Interaction of curcumin on cisplatin cytotoxicity in HeLa and HepG2 carcinoma cells","volume":"50","author":"Becit","year":"2020","journal-title":"Istanbul J. Pharm."},{"key":"10.1016\/j.jinorgbio.2024.112813_bb0465","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.3390\/molecules28155761","article-title":"Disparities in cisplatin-induced cytotoxicity - a meta-analysis of selected cancer cell lines","volume":"28","author":"Cwiklinska-Jurkowska","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jinorgbio.2024.112813_bb0470","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1021\/acs.jmedchem.0c01671","article-title":"A novel Triphenylphosphonium carrier to target mitochondria without uncoupling oxidative phosphorylation","volume":"64","author":"Kulkarni","year":"2021","journal-title":"J. Med. Chem."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013424003386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013424003386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:58:34Z","timestamp":1777492714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013424003386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":94,"alternative-id":["S0162013424003386"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2024.112813","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A critical analysis of the potential of iron heterobimetallic complexes in anticancer research","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2024.112813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112813"}}